A Study to Evaluate the Impact of Direct and Surrogate Advertising and Compliance With the Bill With the Respect to Sale of Tobacco Products Around Educational Institutes

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by Tata Memorial Hospital.
Recruitment status was:  Recruiting
Information provided by:
Tata Memorial Hospital
ClinicalTrials.gov Identifier:
First received: June 11, 2010
Last updated: January 12, 2011
Last verified: June 2010
The Project aims at enlisting the outlets selling tobacco in any form and enlisting the tobacco based advertisements (Direct and Surrogate) directed towards the community, within 100 yards of the selected educational institutes and studying their impact on the students of that institute. This will further be followed by an intervention program directed at the outlet owners which entails creating awareness about the harmful effects of tobacco and the existing bill and thereby assessing any change in Knowledge, Attitude and Practice. The results thus obtained will facilitate implementation of the existing Bill.

Condition Intervention
Assessing and Creating Awareness About the Tobacco Law
Behavioral: Health Education

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: An Intervention Study To Evaluate The Impact Of Direct and Surrogate Advertising And Compliance With The Bill With The Respect To Sale Of Tobacco Products Around Educational Institutes

Further study details as provided by Tata Memorial Hospital:

Primary Outcome Measures:
  • KAP of tobacco vendors about Tobacco Bill [ Time Frame: one year ]
    The primary outcome is assessment of the Knowledge, Attitude and Practice of shop owners towards tobacco ill-effects and the existing Bill and to determine the impact of our intervention on their knowledge regarding the same. Evaluation of the impact these outlets and the advertisements on the students of the selected educational institutes.

Secondary Outcome Measures:
  • post-intervention KAP [ Time Frame: six months ]
    To evaluate the change in the knowledge attitude and practice six months after our planned intervention.

Estimated Enrollment: 480
Study Start Date: May 2010
Estimated Study Completion Date: April 2011
Estimated Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Health Education
    1. Implementing the intervention programme designed for creating awareness about harmful effect of tobacco (smoked and smokeless forms) and the current regulation to the shop-owners.
    2. Administering the questionnaire to objectively asses the impact of direct/ surrogate tobacco advertisements influencing student behavior and perception about tobacco and tobacco products.
    3. Implementing the intervention programme designed for creating awareness about harmful effect of tobacco (smoked and smokeless forms) and the current regulation to the students through interactive sessions with students in their respective educational institute.
  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

Shop owners of the outlets selling tobacco/ tobacco based products, the outlets lying within 100 yards radius of the selected educational institute.

Students in the age- group of 18-25 years from within the selected educational institute.

Exclusion Criteria:

Students outside the 18-25 yrs age group

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01275950

Tata Memorial Hospital
Mumbai, Maharashtra, India, 400012
Sponsors and Collaborators
Tata Memorial Hospital
Principal Investigator: Sharmila A Pimple, MD Tata Memorial Hospital
Principal Investigator: Gauravi A Mishra, MD Tata Memorial Hospital
  More Information

Responsible Party: Sharmila Pimple, Tata Memorial Hospital
ClinicalTrials.gov Identifier: NCT01275950     History of Changes
Other Study ID Numbers: 647 
Study First Received: June 11, 2010
Last Updated: January 12, 2011

Keywords provided by Tata Memorial Hospital:
Tobacco vendor
direct advertisements
surrogate advertisements

ClinicalTrials.gov processed this record on January 19, 2017